(Q35543768)

English

Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers

scientific article published on November 1987

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 August 2017

Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers (English)

1 reference

Europe PubMed Central

8 August 2017

0 references

1 reference

based on heuristic

inferred from title

Escherichia coli

1 reference

based on heuristic

inferred from title

author name string

J S Wolfson

1

1 reference

Europe PubMed Central

8 August 2017

D C Hooper

2

1 reference

Europe PubMed Central

8 August 2017

E Y Ng

3

1 reference

Europe PubMed Central

8 August 2017

K S Souza

4

1 reference

Europe PubMed Central

8 August 2017

G L McHugh

5

1 reference

Europe PubMed Central

8 August 2017

M N Swartz

6

1 reference

Europe PubMed Central

8 August 2017

language of work or name

0 references

publication date

1 November 1987

1 reference

Europe PubMed Central

8 August 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

8 August 2017

31

1 reference

Europe PubMed Central

8 August 2017

1861-1863

1 reference

Europe PubMed Central

8 August 2017

11

1 reference

Europe PubMed Central

8 August 2017

Mutational resistance to 4-quinolone antibacterial agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

Differentiation of fluorinated quinolone antibacterials with Neisseria gonorrhoeae isolates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

In-vitro selection of bacteria resistant to the 4-quinolone agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

Synthesis and antibacterial activities of optically active ofloxacin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

Mechanisms of action of and resistance to ciprofloxacin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

Inhibition of DNA gyrase by optically active ofloxacin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

In vitro studies of S-25930 and S-25932, two new 4-quinolones.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

Mechanism of action of nalidixic acid: Purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=175056

12 July 2018

In-vitro activity of two new quinolone antimicrobial agents, S-25930 and S-25932 compared with that of other agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/2829717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis, absolute configuration, and antibacterial activity of 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H- benzo[ij]quinolizine-2-carboxylic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/2829717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.31.11.1861

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35543768&oldid=1784118686"